Cellebrite cuts 2026 sales guidance after Q2 revenue miss
Cellebrite DI Ltd (NASDAQ: CLBT) reported second-quarter adjusted EPS of 11 cents, met expectations, and posted revenue of $131.14 million versus $131.87 million estimated, while lowering third-quarter and full-year 2026 sales guidance.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.